Medicare Enrolled

Dr. Jonathan Leffert, M.D.

Endocrinology · Dallas, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
9301 N CENTRAL EXPY, Dallas, TX 75231
2143695992
In practice since 2006 (19 years)
NPI: 1891720785 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Leffert from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Leffert? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Leffert

Dr. Jonathan Leffert is an endocrinology in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Leffert performed 3,693 Medicare services across 1,760 unique beneficiaries.

Between the years covered by Open Payments, Dr. Leffert received a total of $3,857 from 37 pharmaceutical and/or device companies across 171 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Leffert is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 11% volume in TX$ $3,857 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,693
Medicare services
Top 11% in TX for endocrinology
1,760
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~194 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)918$91$185
Blood glucose (sugar) test performed by hand-held instrument759$3$15
Hemoglobin A1c test (diabetes monitoring)564$9$40
Office visit, established patient (20-29 min)422$61$125
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report341$26$125
Remote patient monitoring management, 20 min/month230$39$120
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes149$32$100
Ultrasound scan of head and neck soft tissue98$85$375
New patient office visit (45-59 min)95$118$375
New patient office visit (30-44 min)70$79$260
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin26$47$150
Fine needle aspiration biopsy using ultrasound guidance, first growth21$111$300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,857
Total received (2018-2024)
Avg $551/year across 7 years
Top 48% in TX for endocrinology
37
Companies
171
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,469 (90.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$387 (10.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$831
2023
$727
2022
$563
2021
$128
2020
$159
2019
$719
2018
$729

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
SANOFI-AVENTIS U.S. LLC
$579
Novo Nordisk Inc
$330
Amgen Inc.
$321
Tandem Diabetes Care, Inc.
$247
Lilly USA, LLC
$243
Abbott Laboratories
$177
Medtronic, Inc.
$148
Xeris Pharmaceuticals, Inc.
$134
Insulet Corporation
$131
Dexcom, Inc.
$116
MannKind Corporation
$115
CeQur Corporation
$115
Radius Health, Inc.
$112
Janssen Pharmaceuticals, Inc
$108
Mannkind Corporation
$105
Boehringer Ingelheim Pharmaceuticals, Inc.
$98
Shire North American Group Inc
$80
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$75
IBSA Pharma Inc.
$65
Valeritas, Inc.
$59
Amryt Pharma Holdings Ltd
$54
Amneal Pharmaceuticals LLC
$47
Alvogen Inc
$42
AstraZeneca Pharmaceuticals LP
$42
Corcept Therapeutics
$40
Companion Medical, Inc.
$39
Merck Sharp & Dohme Corporation
$36
AbbVie, Inc.
$32
Medtronic MiniMed, Inc.
$30
ABBVIE INC.
$24
Amarin Pharma Inc.
$20
Gilead Sciences, Inc.
$19
Ultragenyx Pharmaceutical Inc.
$16
Nevro Corp.
$15
BETA BIONICS, INC.
$14
AbbVie Inc.
$14
Regeneron Healthcare Solutions, Inc.
$12
Top 3 companies account for 31.9% of total payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM CGM · DIABETES - DISEASE · Dexcom G6 Transmitter · EVENITY · FARXIGA · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · JANUVIA · JARDIANCE · Korlym · LICART · MINIMED 770G · MINIMED 780G · MYCAPSSA · Minimed 670G System · NATPARA · Omnipod · Ozempic · PRALUENT · Prolia · RECORLEV · Rybelsus · SOLIQUA 100/33 · SYNTHROID · Saxenda · Senza · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Victoza · Wegovy · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $104 per 100 Medicare services performed
Looking for a endocrinology in Dallas?
Compare endocrinologys in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
97
Per 100K population
3.7
County median income
$74,149
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Leffert is a clinical cardiology specialist, with above-average Medicare volume (top 11% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Leffert experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Leffert performed 918 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Leffert receive payments from pharmaceutical companies?
Yes. Dr. Leffert received a total of $3,857 from 37 companies across 171 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Leffert's costs compare to other endocrinologys in Dallas?
Dr. Leffert's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Leffert) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →